-+ 0.00%
-+ 0.00%
-+ 0.00%

Johnson & Johnson reported positive survival rates and treatment outcomes using the Impella device in high-risk percutaneous coronary intervention.

Zhitongcaijing·11/01/2026 13:09:00
Listen to the news
Johnson & Johnson reported positive survival rates and treatment outcomes using the Impella device in high-risk percutaneous coronary intervention.